Clinical Trials Logo
  1. Home
  2. Verruca Vulgaris
  3. NCT04620785

Photodynamic Therapy in Treatment of Verrucae

Verruca Vulgaris Clinical Trial

Official title:
PHOTODYNAMIC THERAPY USING METHYLENE BLUE AND INTENSE PULSED LIGHT VERSUS INTENSE PULSED LIGHT ALONE IN TREATMENT OF VERRUCA :A RANDOMIZED CONTROLLED STUDY

Clinical Trial Summary

To assess the efficacy (clinically and dermoscopically) and safety of photodynamic therapy using intralesional injection of 4% methylene blue solution as a photosensitizer with IPL versus IPL only in treatment of warts.

Clinical Trial Description

This study will be conducted on: Eighty patients suffering of verruca (male and female) divided randomly into three groups: group A, B&C : Group A: 30 patients will undergo photodynamic therapy using intralesional 4%methylene blue solution and IPL. Group B: 30 patients will undergo IPL only. Group C (control group):20 patients will undergo intralesional saline. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04620785
Study type Interventional
Source Alexandria University
Contact
Status Recruiting
Phase N/A
Start date January 1, 2020
Completion date May 1, 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05937672 - Cold Atmospheric Plasma Device Extension Study Phase 3
Completed NCT00328991 - Clinical Trial Evaluating Efficacy of Duct Tape for Treatment of Warts N/A
Recruiting NCT05409365 - Assessment of Squamous Cell Carcinoma antigen2 in Verruca Vulgaris
Completed NCT03487549 - Cantharidin and Occlusion in Verruca Epithelium Phase 2
Completed NCT01084824 - A Trial Examining the Treatment of Common Warts With Combination Liquid Nitrogen (LN2) and Cantharidin N/A
Terminated NCT01609530 - Pulsed 1064nm Nd:YAG in the Treatment of Verruca Vulgaris Versus Conventional Therapy With Liquid Nitrogen Cryotherapy N/A
Completed NCT04793529 - Is Involucrin Has a Role in Verruca Vulgaris? A Clinical and Immunohistochemical Study N/A
Recruiting NCT05799157 - Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts Phase 2
Completed NCT05070754 - Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca Phase 4
Completed NCT02748902 - Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands. Phase 1
Completed NCT02483455 - ALC-919 For The Treatment Of Common Warts Phase 2